The new crop of mAbs represents a resounding level of validation for the HuMab transgenic mouse technology developed by Nils Lonberg, initially at Palo Alto, California–based GenPharm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback